Jang-Young Choi - Search Results

Year	Number of Results
2002	3
2003	3
2004	7
2005	9
2006	10
2007	10
2008	11
2009	19
2010	20
2011	18
2012	18
2013	20
2014	12
2015	14
2016	16
2017	12
2018	10
2019	15
2020	15
2021	19
2022	14
2023	11
2024	23
2025	9

1

EpCAM-high liver cancer stem cells resist natural killer cell-mediated cytotoxicity by upregulating CEACAM1.

Park DJ, Sung PS, Kim JH, Lee GW, Jang JW, Jung ES, Bae SH, Choi JY, Yoon SK. Park DJ, et al. Among authors: choi jy. J Immunother Cancer. 2020 Mar;8(1):e000301. doi: 10.1136/jitc-2019-000301. J Immunother Cancer. 2020. PMID: 32221015 Free PMC article.

2

Intrahepatic IgA complex induces polarization of cancer-associated fibroblasts to matrix phenotypes in the tumor microenvironment of HCC.

Park JG, Roh PR, Kang MW, Cho SW, Hwangbo S, Jung HD, Kim HU, Kim JH, Yoo JS, Han JW, Jang JW, Choi JY, Yoon SK, You YK, Choi HJ, Ryu JY, Sung PS. Park JG, et al. Among authors: choi jy. Hepatology. 2024 Nov 1;80(5):1074-1086. doi: 10.1097/HEP.0000000000000772. Epub 2024 Feb 15. Hepatology. 2024. PMID: 38466639

3

Local Ablation for Hepatocellular Carcinoma: 2024 Expert Consensus-Based Practical Recommendations of the Korean Liver Cancer Association.

Han S, Sung PS, Park SY, Kim JW, Hong HP, Yoon JH, Chung DJ, Kwon JH, Lim S, Kim JH, Shin SK, Kim TH, Lee DH, Choi JY; Research Committee of the Korean Liver Cancer Association. Han S, et al. Among authors: choi jy. Gut Liver. 2024 Sep 15;18(5):789-802. doi: 10.5009/gnl240350. Epub 2024 Sep 3. Gut Liver. 2024. PMID: 39223081 Free PMC article. Review.

4

Chitinase 1: a novel therapeutic target in metabolic dysfunction-associated steatohepatitis.

Cha JH, Park NR, Cho SW, Nam H, Yang H, Jung ES, Jang JW, Choi JY, Yoon SK, Sung PS, Bae SH. Cha JH, et al. Among authors: choi jy. Front Immunol. 2024 Sep 23;15:1444100. doi: 10.3389/fimmu.2024.1444100. eCollection 2024. Front Immunol. 2024. PMID: 39381000 Free PMC article.

5

RECIST 1.1, mRECIST, and Choi criteria for evaluating treatment response and survival outcomes in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab.

Kim DH, Min EJ, Kim B, Choi JY, Jang JW, Sung PS, Han JW, Kim H, Choi JI. Kim DH, et al. Among authors: choi jy. Eur Radiol. 2025 Feb;35(2):684-694. doi: 10.1007/s00330-024-10986-z. Epub 2024 Jul 30. Eur Radiol. 2025. PMID: 39080067

6

Androgen dysfunction in non-alcoholic fatty liver disease: Role of sex hormone binding globulin.

Song MJ, Choi JY. Song MJ, et al. Among authors: choi jy. Front Endocrinol (Lausanne). 2022 Nov 22;13:1053709. doi: 10.3389/fendo.2022.1053709. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36482993 Free PMC article. Review.

7

Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in virologically suppressed patient with chronic hepatitis B.

Nam H, Han JW, Lee SK, Yang H, Lee HL, Sung PS, Song MJ, Kwon JH, Jang JW, Chang UI, Kim CW, Nam SW, Bae SH, Choi JY, Yoon SK, Yang JM, Kim HY. Nam H, et al. Among authors: choi jy. J Gastroenterol Hepatol. 2024 Aug;39(8):1673-1683. doi: 10.1111/jgh.16593. Epub 2024 May 1. J Gastroenterol Hepatol. 2024. PMID: 38690711

8

Intrahepatic inflammatory IgA⁺PD-L1^high monocytes in hepatocellular carcinoma development and immunotherapy.

Sung PS, Park DJ, Roh PR, Mun KD, Cho SW, Lee GW, Jung ES, Lee SH, Jang JW, Bae SH, Choi JY, Choi J, Ahn J, Yoon SK. Sung PS, et al. Among authors: choi jy. J Immunother Cancer. 2022 May;10(5):e003618. doi: 10.1136/jitc-2021-003618. J Immunother Cancer. 2022. PMID: 35577505 Free PMC article.

9

Analysis of Immune-Related Adverse Events of Atezolizumab and Bevacizumab in Patients with Hepatocellular Carcinoma: A Multicentre Cohort Study.

Nam H, Lee J, Han JW, Lee SK, Yang H, Lee HL, Sung PS, Kim HY, Kim SH, Song MJ, Kwon JH, Kim CW, Nam SW, Bae SH, Choi JY, Yoon SK, Jang JW. Nam H, et al. Among authors: choi jy. Liver Cancer. 2023 Dec 21;13(4):413-425. doi: 10.1159/000535839. eCollection 2024 Aug. Liver Cancer. 2023. PMID: 39114756 Free PMC article.

10

A risk prediction model for hepatocellular carcinoma after hepatitis B surface antigen seroclearance.

Yang H, Bae SH, Nam H, Lee HL, Lee SW, Yoo SH, Song MJ, Kwon JH, Nam SW, Choi JY, Yoon SK, Jang JW. Yang H, et al. Among authors: choi jy. J Hepatol. 2022 Sep;77(3):632-641. doi: 10.1016/j.jhep.2022.03.032. Epub 2022 Apr 7. J Hepatol. 2022. PMID: 35398462

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

291 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

291 results

Results by year